Low PE high ROE multibagger stock: This small-cap company has announced a revised floor price for the delisting of its shares!
The shares of the company have a PE of 2.76x and a ROE of 99.70 per cent.
TTK Healthcare Ltd announced that a received communication dated July 04, 2023 from the acquirers along with a certificate dated July 04, 2023 issued by Mr N Sridharan, Proprietor, M/s Aiyar & Co., Chartered Accountants, Chennai (Firm Regn. No.000063S / Membership No.20503), stating that based on the views and observations received from the Stock Exchanges, the Floor Price has now been recomputed as Rs 1,201.30 per Equity Share, by determining the Reference Date as the date of the Board Meeting (i.e.) April 20, 2023, in which the delisting proposal was considered and approved, in accordance with Regulations 20(2) and 20(3) of the SEBI Delisting Regulations.
The said communication received from the Acquirer(s) along with the Certificate of the Revised Floor Price issued by M/s Aiyar & Co., Chartered Accountants, has been taken on record by the Board of Directors through Circular Resolution dated July 04, 2023. Earlier the floor price was Rs 1,051.31 per equity share.
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.
DSIJ offers a service 'Tiny Treasure' with recommendations for Small-Cap stocks based on research and analysis to help subscribers make informed investment decisions. If this interests you, then do download the service details pdf here
On Tuesday, shares of TTK Healthcare Ltd surged 0.53 per cent to Rs 1,251 per share from its previous closing of Rs 1,244.50. The stock has a 52-week high of Rs 1,450 and a 52-week low of Rs 781.30.
According to the financials, TTK Healthcare Ltd has a market cap of over Rs 1,700 crore. The company reported amazing numbers in its Quarterly Results and annual results. Additionally, the company has delivered good profit growth of 104 per cent CAGR over last 5 years and has been maintaining a healthy dividend payout of 18.20 per cent.
The shares of the company have a PE of 2.76x and a ROE of 99.70 per cent. The stock is up by 55 per cent in just 1 year and over 200 per cent in 3 years. Investors should keep an eye on this small-cap stock.